- Original article
- Open Access
Correlation between pleural fluid cytology and magnitude of pleural invasion in patients with malignant pleural mesothelioma
Egyptian Journal of Bronchology volume 10, pages 238–242 (2016)
Malignant pleural mesothelioma (MPM) is an aggressive tumor commonly triggered by exposure to asbestos, and commonly presented with unilateral pleural effusion. Pleural fluid cytological assessment is often the first diagnostic step that leads to a confirmed diagnosis in a relatively small percentage of cases. Medical thoracoscopy is considered as the procedure of choice to achieve a definite diagnosis and evaluate the extent of the disease.
Aim of the study
The aim of this study was to assess the correlation between pleural fluid cytological yield and the invasion of different pleural surfaces detected by means of medical thoracoscopy.
Patients and methods
In this retrospective study, the medical records of all patients with confirmed MPM who underwent medical thoracoscopy at the Chest Department of Ain Shams University Hospitals from May 2012 to May 2016 were analyzed. Patients were included only if the results of pleural fluid cytology were available, as well as the detailed reports of medical thoracoscopy.
We included 85 patients with MPM in this study, 71 male and 14 female, with a mean age of 61.56±8.75 years. Types of MPM were epitheliod type (64.7%), biphasic type (23.5%), and sarcomatoid type (11.8%). Positive pleural fluid cytology was found in 24 patients (28.2%). Medical thoracoscopy demonstrated parietal pleural invasion in all patients (100%) and visceral pleural invasion in 26 patients (30.5%). Visceral pleural invasion was found in 83.3% of patients with positive pleural fluid cytology. Our results demonstrated that the presence of visceral pleural invasion could predict a positive pleural fluid cytology with a sensitivity of 79.17%, specificity of 88.52%, positive predictive value of 73.08%, and negative predictive value of 91.83. The pattern of visceral pleural invasion had no impact on the results of pleural fluid cytology (P>0.05).
The results of our study showed that the overall diagnostic yield of pleural fluid cytology in MPM is 28.2%. Positive pleural fluid cytology results were found to be significantly higher in cases with visceral pleural invasion, and, as visceral pleural invasion indicates a more advanced disease, the positive pleural fluid cytological results may be considered an indicator for advanced MPM.
Robinson BW, Musk AW, Lake RA. Malignant mesothelioma. Lancet 2005; 366:397–408.
Stahel RA, Weder W, Lievens Y, Felip E OESMO guidelines working group. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow up. Ann Oncol 2010; 21 (Suppl 5):v126–v128.
Scherpereel A. The experts’ conference of the Société de Pneumologie de Langue Française (SPLF) on malignant pleural mesothelioma (MPM): useful and necessary recommendations. Rev Mal Respir 2006; 23(Pt 3):11S5–11S6S.
Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, de Vuyst P, et al., European Respiratory Society/European Society of Thoracic Surgeons Task Force. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J 2010; 35:479–495
British Thoracic Society Standards of Care Committee. BTS statement on malignant mesothelioma in the UK, 2007. Thorax 2007; 62:(Suppl 2): ii1–ii19.
Pinelli V, Laroumagne S, Sakr L, Marchetti GP, Tassi GF, Astoul P. Pleural fluid cytological yield and visceral pleural invasion in patients with epithelioid malignant pleural mesothelioma. J Thorac Oncol 2012; 7:595–598.
Renshaw AA, Dean BR, Antman KH, Sugarbaker DJ, Cibas ES. The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest 1997; 111:106–109.
Rakha EA, Patil S, Abdulla K, Abdulkader M, Chaudry Z, Soomro IN. The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Diagn Cytopathol 2010; 38:874–879.
O’Byrne KJ, Edwards JG, Waller DA. Clinico-pathological and biological prognostic factors in pleural malignant mesothelioma. Lung Cancer 2004; 45:(Suppl 1):S45–S45 S48.
Steele JP. Prognostic factors for mesothelioma. Hematol Oncol Clin North Am 2005; 19:1041–1052.
Herndon JE, Green MR, Chahinian AP, Corson JM, Suzuki Y, Vogelzang NJ. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest 1998; 113:723–731.
Rusch VW, Venkatraman ES. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg 1999; 68:1799–1804.
Boutin C, Rey F, Gouvernet J, Viallat JR, Astoul P, Ledoray V. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: Prognosis and staging. Cancer 1993; 72:394–404.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
About this article
Cite this article
Shoukri, A.M., Riad, N.M. Correlation between pleural fluid cytology and magnitude of pleural invasion in patients with malignant pleural mesothelioma. Egypt J Bronchol 10, 238–242 (2016). https://doi.org/10.4103/1687-8426.193645
- malignant mesothelioma
- medical thoracoscopy
- pleural fluid cytology